Cadre Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CDRE research report →
Range $40 – $43
Price Chart
About the company
Cadre Holdings, Inc. specializes in manufacturing and distributing vital safety and survival gear designed to protect individuals in perilous or life-threatening environments, both within the United States and globally. The company operates through two distinct divisions: its proprietary Products segment and a Distribution arm.
- CEO
- Warren Kanders
- IPO
- 2021
- Employees
- 2,533
- HQ
- Jacksonville, FL, US
Get TickerSpark's AI analysis on CDRE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.43B
- P/E
- 38.53
- Fwd P/E
- 33.46
- PEG
- -5.17
- P/S
- 2.09
- P/B
- 4.14
- EV/EBITDA
- 19.73
- Div Yield
- 1.18%
- Gross Margin
- 40.75%
- Op Margin
- 10.88%
- Net Margin
- 5.26%
- ROE
- 10.76%
- ROIC
- 6.57%
Latest fiscal year · YoY change
- Revenue
- $610.31M+7.5%
- Gross Profit
- $251.72M+7.8%
- Op Income
- $75.05M
- Net Income
- $44.14M+22.2%
- EPS
- $1.08+20.0%
- OCF Growth
- +100.5%
- FCF Growth
- +117.7%
- 52W High
- $48.76
- 52W Low
- $25.73
- 50D MA
- $30.38
- 200D MA
- $35.85
- Beta
- 1.32
- RSI (14)
- 57
- Avg Volume
- 386.38K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Cadre delivered a strong Q2 with 32% net sales growth, 56% adjusted EBITDA growth, record backlog, and raised full-year guidance on broad-based demand and recent acquisitions.· August 6, 2026
- Net sales rose to $207.1 million, up 32% year over year and 5% organically; adjusted EBITDA increased 56% year over year.
- Gross profit was $87.1 million, up 36%, and gross margin expanded 120 basis points year over year, or 209 basis points excluding inventory step-up amortization.
- Backlog increased to a new record for the second straight quarter, with especially strong demand in EOD, armor, duty gear and nuclear.
- Management raised 2026 guidance and said full-year revenue and adjusted EBITDA should increase well above 20%.
- Alien Gear and TYR Tactical both performed above expectations, while management said it expects at least one more acquisition in 2026.
Q2 net sales were $207.1 million, up 32% year over year and 5% organically. Gross profit was $87.1 million, up 36% year over year, and gross margin expanded 120 basis points year over year, or 209 basis points excluding inventory step-up amortization. Adjusted EBITDA increased 56% year over year. Net income was affected by $2 million of inventory step-up amortization, $5.9 million of contingent consideration expense, and $6.6 million of FX headwinds. For 2026, Cadre now expects net sales of $749 million to $769 million and adjusted EBITDA of $139 million to $144 million, implying an 18.6% margin; organic revenue growth is still expected to be 3% to 5%. Management also guided to Q3 revenue of about $190 million with adjusted EBITDA margins of about 18%, and said Q4 should look very similar to Q2.
Warren Kanders framed the quarter as another period of strong execution across a more diversified portfolio, citing mission-critical demand in public safety, defense and nuclear markets. He emphasized that Cadre is seeing durable demand, a record backlog, and multiple growth avenues from both large strategic deals and smaller bolt-on acquisitions. His tone was confident and constructive, repeatedly pointing to the company’s stronger scale, cash generation and balance sheet as reasons it can pursue more M&A while sustaining growth.
Blaine Browers focused on the numbers and the guide raise, highlighting $207.1 million in sales, $87.1 million in gross profit, 56% adjusted EBITDA growth, and margin expansion despite $2 million of inventory step-up amortization, $5.9 million of contingent consideration expense, and $6.6 million of FX headwinds. He said net leverage was 2.5x at June 30, giving Cadre financial flexibility, and noted roughly $455 million deployed across 7 transactions over the last 4 years. He also said the updated 2026 outlook fully includes Alien Gear, with midpoint growth of 24.4% for revenue and 26.7% for adjusted EBITDA, and that the company still expects organic growth of 3% to 5%.
Analysts focused on the nuclear backlog mix, nuclear margin quality, the sustainability of the 5% organic growth rate, margin drivers in the second half, and how much Alien Gear and TYR Tactical can contribute. Management said nuclear backlog growth has been led mainly by commercial nuclear energy and environmental remediation, with additional strength in Europe, while nuclear margins should normalize by region in the back half. On public safety, management said demand remained strong and that several wins, including the FBI ballistic panel program and BEMO, support the outlook; it also said the Alien Gear integration is progressing and that the business did $4.8 million in the quarter but was not fully baked into guidance at $11 million for the year.
The call showed broad demand strength across public safety and nuclear, with organic growth, a record backlog, and multiple contract wins supporting the updated outlook. Management sounded increasingly confident that recent acquisitions are outperforming and could add both revenue and margin benefits as integration progresses.
Management acknowledged some near-term margin mix volatility, especially in nuclear and in Q3, as well as potential timing shifts from government procurement. They also flagged that the downblending executive order still pressures less than 8% of nuclear revenue and that Alien Gear remains early in integration, with some caution left in the guide after its bankruptcy situation.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 65.7%
- Shares Outstanding
- 42.80M
- Float Shares
- 28.13M
of shares held by institutions
171 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CDRE, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert CisnerosHouse · CA31 | Buy | Jun 30, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Mar 16, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Jun 11, 25 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Apr 17, 25 | Filing → |
| Josh GottheimerHouse · NJ05 | Buy | Jan 27, 25 | Filing → |
| Josh GottheimerHouse · NJ05 | Buy | Dec 6, 24 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Dec 27, 24 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 2.94M | ▲ 310.50K |
| Greenhouse Funds Lllp | 2.87M | ▲ 286 |
| Reinhart Partners, Inc. | 2.74M | ▲ 500.48K |
| Fmr LLC | 2.48M | ▼ 843.57K |
| State Street Corp | 1.95M | ▲ 553.41K |
| Vanguard Group Inc | 1.67M | ▼ 26.44K |
| Capital International Investors | 1.62M | ▲ 361.66K |
| Vanguard Capital Management LLC | 1.32M | ▲ 76.81K |
| Gw&K Investment Management, LLC | 1.27M | ▲ 227.19K |
| Capital World Investors | 1.21M | ▲ 32.88K |
| Wynnefield Capital Inc | 1.21M | ▲ 55.00K |
| Select Equity Group, L.P. | 1.18M | ▲ 433.42K |
Held by 194 ETFs
Biggest fund positions in CDRE by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 17, 26 | Williams Brad | other | 45,972 |
| Aug 17, 26 | Williams Brad | sell | 104 |
| Aug 17, 26 | Williams Brad | other | 42,770 |
| Aug 17, 26 | Williams Brad | sell | 88,638 |
| Aug 17, 26 | Williams Brad | other | 42,770 |
| Aug 17, 26 | Williams Brad | other | 45,972 |
| Jun 18, 26 | KANDERS WARREN B | sell | 25,000 |
| Jun 22, 26 | KANDERS WARREN B | sell | 50,000 |
| Jun 16, 26 | Kissel Mary E. | other | 17,393 |
| Jun 16, 26 | QUIGLEY WILLIAM G III | other | 17,393 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CDRE coverage
Recent articles, reports, and earnings notes.
No research on CDRE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CDRE report →Cadre Q2 Earnings Call Highlights
marketbeat.com · Aug 7
Cadre Holdings, Inc. (CDRE) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 7
Cadre Holdings, Inc. (CDRE) Lags Q2 Earnings Estimates
zacks.com · Aug 5
Here's What Key Metrics Tell Us About Cadre Holdings, Inc. (CDRE) Q2 Earnings
zacks.com · Aug 5
Cadre Holdings Reports Second Quarter 2026 Financial Results
businesswire.com · Aug 5
Cadre Holdings: Recurring Demand And H2 Potential Margin Inflection
seekingalpha.com · Jul 30
Caxton Associates LLP Makes New Investment in Cadre Holdings, Inc. $CDRE
defenseworld.net · Jul 28
Cadre Holdings Announces Second Quarter 2026 Earnings and Conference Call Information
businesswire.com · Jul 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.